Characterization of the neuropsychological phenotype of glycine N-methyltransferase-/- mice and evaluation of its responses to clozapine and sarcosine treatments

Ching Ping Yang, Hsiang An Wang, Tung Hu Tsai, Angela Fan, Chia Lang Hsu, Chun Jung Chen, Chen Jee Hong, Yi Ming Arthur Chen

研究成果: 雜誌貢獻 › 文章

8 引文 (Scopus)

摘要

Glycine N-methyltransferase (GNMT) affects cellular methylation capacity through regulating the ratio between S-adenosylmethionine (SAM) and S-adenosylhomocysteine (SAH). The product of its enzymatic reaction-sarcosine has antipsychotic effect in patients with schizophrenia. In this study, through RT-PCR and immunohistochemical staining, we demonstrated that GNMT expressed in various neurons located in the cerebral cortex, hippocampus, substantia nigra and cerebellum. Compared to the wild-type mice, Gnmt-/- mice had significantly lower level of sarcosine in the cerebral cortex. Real-time PCR identified genes involved in the methionine metabolism (Dnmt1 and Dnmt3a), ErbB (Nrg1 and ErbB4) and mTOR (Akt2, S6, S6k1 and S6k2) signaling pathways were dysregulated significantly in the cortex of Gnmt-/- mice. Acoustic startle reflex test demonstrated that Gnmt-/- mice had significantly lower level of prepulse inhibition and the deficit was ameliorated through clozapine or sarcosine treatment. Furthermore, liver-specific-human-GNMT transgenic with Gnmt-/- (Tg-GNMT/Gnmt-/-) mice were used to rule out that the phenotype was due to abnormal liver function. In summary, the neuropsychological abnormalities found in Gnmt-/- mice may represent an endophenotype of schizophrenia. GNMT plays an important role in maintaining normal physiological function of brain and Tg-GNMT/Gnmt-/- mice are useful models for development of therapeutics for patients with schizophrenia.
原文英語
頁（從 - 到）596-606
頁數11
期刊European Neuropsychopharmacology
卷22
發行號8
DOIs
出版狀態已發佈 - 八月 1 2012
對外發佈Yes

指紋

Glycine N-Methyltransferase
Sarcosine
Clozapine
Phenotype
Schizophrenia
Cerebral Cortex
Therapeutics
Startle Reflex
S-Adenosylhomocysteine
Endophenotypes
S 6
S-Adenosylmethionine
Liver
Substantia Nigra
Methionine
Cerebellum
Methylation
Antipsychotic Agents
Real-Time Polymerase Chain Reaction
Hippocampus

ASJC Scopus subject areas

  • Pharmacology
  • Neurology
  • Clinical Neurology
  • Psychiatry and Mental health
  • Biological Psychiatry
  • Pharmacology (medical)

引用此文

Characterization of the neuropsychological phenotype of glycine N-methyltransferase-/- mice and evaluation of its responses to clozapine and sarcosine treatments. / Yang, Ching Ping; Wang, Hsiang An; Tsai, Tung Hu; Fan, Angela; Hsu, Chia Lang; Chen, Chun Jung; Hong, Chen Jee; Chen, Yi Ming Arthur.

於: European Neuropsychopharmacology, 卷 22, 編號 8, 01.08.2012, p. 596-606.

研究成果: 雜誌貢獻 › 文章

Yang, CP, Wang, HA, Tsai, TH, Fan, A, Hsu, CL, Chen, CJ, Hong, CJ & Chen, YMA 2012, 'Characterization of the neuropsychological phenotype of glycine N-methyltransferase-/- mice and evaluation of its responses to clozapine and sarcosine treatments', European Neuropsychopharmacology, 卷 22, 編號 8, 頁 596-606. https://doi.org/10.1016/j.euroneuro.2011.12.007
Yang CP, Wang HA, Tsai TH, Fan A, Hsu CL, Chen CJ 等. Characterization of the neuropsychological phenotype of glycine N-methyltransferase-/- mice and evaluation of its responses to clozapine and sarcosine treatments. European Neuropsychopharmacology. 2012 8月 1;22(8):596-606. https://doi.org/10.1016/j.euroneuro.2011.12.007
Yang, Ching Ping ; Wang, Hsiang An ; Tsai, Tung Hu ; Fan, Angela ; Hsu, Chia Lang ; Chen, Chun Jung ; Hong, Chen Jee ; Chen, Yi Ming Arthur. / Characterization of the neuropsychological phenotype of glycine N-methyltransferase-/- mice and evaluation of its responses to clozapine and sarcosine treatments. 於: European Neuropsychopharmacology. 2012 ; 卷 22, 編號 8. 頁 596-606.
@article{7f61b18b551d457a89c9677281766643,
title = "Characterization of the neuropsychological phenotype of glycine N-methyltransferase-/- mice and evaluation of its responses to clozapine and sarcosine treatments",
abstract = "Glycine N-methyltransferase (GNMT) affects cellular methylation capacity through regulating the ratio between S-adenosylmethionine (SAM) and S-adenosylhomocysteine (SAH). The product of its enzymatic reaction-sarcosine has antipsychotic effect in patients with schizophrenia. In this study, through RT-PCR and immunohistochemical staining, we demonstrated that GNMT expressed in various neurons located in the cerebral cortex, hippocampus, substantia nigra and cerebellum. Compared to the wild-type mice, Gnmt-/- mice had significantly lower level of sarcosine in the cerebral cortex. Real-time PCR identified genes involved in the methionine metabolism (Dnmt1 and Dnmt3a), ErbB (Nrg1 and ErbB4) and mTOR (Akt2, S6, S6k1 and S6k2) signaling pathways were dysregulated significantly in the cortex of Gnmt-/- mice. Acoustic startle reflex test demonstrated that Gnmt-/- mice had significantly lower level of prepulse inhibition and the deficit was ameliorated through clozapine or sarcosine treatment. Furthermore, liver-specific-human-GNMT transgenic with Gnmt-/- (Tg-GNMT/Gnmt-/-) mice were used to rule out that the phenotype was due to abnormal liver function. In summary, the neuropsychological abnormalities found in Gnmt-/- mice may represent an endophenotype of schizophrenia. GNMT plays an important role in maintaining normal physiological function of brain and Tg-GNMT/Gnmt-/- mice are useful models for development of therapeutics for patients with schizophrenia.",
keywords = "Endophenotype, Glycine N-methyltransferase, Knockout mice, Prepulse inhibition, Sarcosine, Schizophrenia",
author = "Yang, {Ching Ping} and Wang, {Hsiang An} and Tsai, {Tung Hu} and Angela Fan and Hsu, {Chia Lang} and Chen, {Chun Jung} and Hong, {Chen Jee} and Chen, {Yi Ming Arthur}",
year = "2012",
month = "8",
day = "1",
doi = "10.1016/j.euroneuro.2011.12.007",
language = "English",
volume = "22",
pages = "596--606",
journal = "European Neuropsychopharmacology",
issn = "0924-977X",
publisher = "Elsevier",
number = "8",

}

TY - JOUR

T1 - Characterization of the neuropsychological phenotype of glycine N-methyltransferase-/- mice and evaluation of its responses to clozapine and sarcosine treatments

AU - Yang, Ching Ping

AU - Wang, Hsiang An

AU - Tsai, Tung Hu

AU - Fan, Angela

AU - Hsu, Chia Lang

AU - Chen, Chun Jung

AU - Hong, Chen Jee

AU - Chen, Yi Ming Arthur

PY - 2012/8/1

Y1 - 2012/8/1

N2 - Glycine N-methyltransferase (GNMT) affects cellular methylation capacity through regulating the ratio between S-adenosylmethionine (SAM) and S-adenosylhomocysteine (SAH). The product of its enzymatic reaction-sarcosine has antipsychotic effect in patients with schizophrenia. In this study, through RT-PCR and immunohistochemical staining, we demonstrated that GNMT expressed in various neurons located in the cerebral cortex, hippocampus, substantia nigra and cerebellum. Compared to the wild-type mice, Gnmt-/- mice had significantly lower level of sarcosine in the cerebral cortex. Real-time PCR identified genes involved in the methionine metabolism (Dnmt1 and Dnmt3a), ErbB (Nrg1 and ErbB4) and mTOR (Akt2, S6, S6k1 and S6k2) signaling pathways were dysregulated significantly in the cortex of Gnmt-/- mice. Acoustic startle reflex test demonstrated that Gnmt-/- mice had significantly lower level of prepulse inhibition and the deficit was ameliorated through clozapine or sarcosine treatment. Furthermore, liver-specific-human-GNMT transgenic with Gnmt-/- (Tg-GNMT/Gnmt-/-) mice were used to rule out that the phenotype was due to abnormal liver function. In summary, the neuropsychological abnormalities found in Gnmt-/- mice may represent an endophenotype of schizophrenia. GNMT plays an important role in maintaining normal physiological function of brain and Tg-GNMT/Gnmt-/- mice are useful models for development of therapeutics for patients with schizophrenia.

AB - Glycine N-methyltransferase (GNMT) affects cellular methylation capacity through regulating the ratio between S-adenosylmethionine (SAM) and S-adenosylhomocysteine (SAH). The product of its enzymatic reaction-sarcosine has antipsychotic effect in patients with schizophrenia. In this study, through RT-PCR and immunohistochemical staining, we demonstrated that GNMT expressed in various neurons located in the cerebral cortex, hippocampus, substantia nigra and cerebellum. Compared to the wild-type mice, Gnmt-/- mice had significantly lower level of sarcosine in the cerebral cortex. Real-time PCR identified genes involved in the methionine metabolism (Dnmt1 and Dnmt3a), ErbB (Nrg1 and ErbB4) and mTOR (Akt2, S6, S6k1 and S6k2) signaling pathways were dysregulated significantly in the cortex of Gnmt-/- mice. Acoustic startle reflex test demonstrated that Gnmt-/- mice had significantly lower level of prepulse inhibition and the deficit was ameliorated through clozapine or sarcosine treatment. Furthermore, liver-specific-human-GNMT transgenic with Gnmt-/- (Tg-GNMT/Gnmt-/-) mice were used to rule out that the phenotype was due to abnormal liver function. In summary, the neuropsychological abnormalities found in Gnmt-/- mice may represent an endophenotype of schizophrenia. GNMT plays an important role in maintaining normal physiological function of brain and Tg-GNMT/Gnmt-/- mice are useful models for development of therapeutics for patients with schizophrenia.

KW - Endophenotype

KW - Glycine N-methyltransferase

KW - Knockout mice

KW - Prepulse inhibition

KW - Sarcosine

KW - Schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=84864529944&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864529944&partnerID=8YFLogxK

U2 - 10.1016/j.euroneuro.2011.12.007

DO - 10.1016/j.euroneuro.2011.12.007

M3 - Article

C2 - 22264868

AN - SCOPUS:84864529944

VL - 22

SP - 596

EP - 606

JO - European Neuropsychopharmacology

JF - European Neuropsychopharmacology

SN - 0924-977X

IS - 8

ER -

存取文件